SNOAW

Sonoma Pharmaceuticals (SNOAW)

Sonoma Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNOAW

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2020/02/28	07 : 00	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces Asset Purchase Agreement with Middle East Partner MicroSafe Group	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2020/02/15	07 : 30	GlobeNewswire Inc.	Sonoma Pharmaceuticals Reports Third Quarter FY 2020 Financial Results	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2020/01/24	06 : 43	GlobeNewswire Inc.	Sonoma Pharmaceuticals Engages Maxim Group LLC to Explore Strategic Opportunities for its U.S. Dermatology Division	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2019/11/30	06 : 42	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces Closing of $1.6 Million Public Offering of Common Stock	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2019/11/27	00 : 10	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces Pricing of Approximately $1.6 million Public Offering of Common Stock	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2019/11/26	09 : 54	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces Proposed Public Offering of Common Stock	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2019/11/15	08 : 00	GlobeNewswire Inc.	Sonoma Pharmaceuticals Reports Second Quarter FY 2020 Financial Results	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2019/10/02	06 : 09	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces Management Changes	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2019/08/14	06 : 35	GlobeNewswire Inc.	Sonoma Pharmaceuticals Reports First Quarter FY 2020 Financial Results	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2019/07/12	22 : 00	GlobeNewswire Inc.	Sonoma Pharmaceuticals Regains Compliance with Nasdaq® Minimum Bid Price Rule	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2019/07/09	05 : 03	GlobeNewswire Inc.	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2019 Financial Results	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2019/06/20	05 : 05	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces 1-for-9 Reverse Split of Outstanding Common Stock	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2019/05/22	05 : 05	GlobeNewswire Inc.	Sonoma Pharmaceuticals Sells Animal Health Rights in Asia and Europe for $2.7 million	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2019/03/13	07 : 30	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces Substantial Cost-Cutting Measures	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/12/15	07 : 30	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces Management Changes	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/11/18	01 : 01	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces Pricing of Public Offering of Units	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/11/09	06 : 03	GlobeNewswire Inc.	Sonoma Pharmaceuticals Reports Record Revenue in Second Quarter FY 2019	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/11/01	20 : 05	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces Second Quarter FY 2019 Financial Results and Conference Call	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/10/25	20 : 05	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces Newly Published Results from Study of Hypochlorous Acid in Management of Hypertrophic and Ke...	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/10/17	20 : 05	GlobeNewswire Inc.	Sonoma Pharmaceuticals Launches New Ceramax™ Skin Barrier Lotion with Skin-Enriching Lipogrid Technology™	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/09/26	20 : 05	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces Licensing of Antimicrobial Hypochlorous Acid Solution for Management of Blepharitis in the S...	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/09/19	20 : 05	GlobeNewswire Inc.	Sonoma Pharmaceuticals Appoints Phillipe Weigerstorfer to Board of Directors	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/08/28	20 : 05	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces Results from Study of Sonoma’s Performance-Stabilized HOCl™ (Hypochlorous Acid) in Manag...	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/08/09	05 : 05	GlobeNewswire Inc.	Sonoma Pharmaceuticals Reports First Quarter FY 2019 Financial Results	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/07/25	20 : 05	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces First Quarter FY 2019 Financial Results and Conference Call	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/06/14	05 : 05	GlobeNewswire Inc.	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2018 Financial Results	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/06/05	20 : 05	GlobeNewswire Inc.	U.SK, dermatology arm of Brazilian NC Group, and Sonoma Pharmaceuticals Enter into License Agreement for Exclusive Rights to ...	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/05/31	20 : 05	GlobeNewswire Inc.	Sonoma Pharmaceuticals Announces Fiscal Year/Fourth Quarter 2018 Financial Results and Conference Call	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/05/08	20 : 00	GlobeNewswire Inc.	Sonoma Pharmaceuticals Names Marc Umscheid Chief Operating Officer	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc
2018/04/17	20 : 04	GlobeNewswire Inc.	Sonoma Pharmaceuticals Receives Four New UAE Regulatory Approvals that Include Acne and Anti-Fungal Products	NASDAQ:SNOAW	Sonoma Pharmaceuticals Inc